Dr. Natasha Press, MD, FRCPC
Clinical Associate Professor, Division of Infectious Diseases,
Department of Medicine, Faculty of Medicine,
University of British Columbia
The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025